论文信息 - Frontline Treatment with Ibrutinib with Rituximab (IR) Combination Is Highly Effective in Elderly (≥65 years) Patients with Mantle Cell Lymphoma (MCL) - Results from a Phase II Trial - 字舞流文

Frontline Treatment with Ibrutinib with Rituximab (IR) Combination Is Highly Effective in Elderly (≥65 years) Patients with Mantle Cell Lymphoma (MCL) - Results from a Phase II Trial

Michael L. Wang | Linghua Wang | K. Patel | P. Jain | R. Kanagal-Shamanna | Changying Jiang | K. Nomie | J. Westin | S. Neelapu | S. Thirumurthi | S. Iyer | H. Lee | F. Hagemeister | G. Tang | J. Romaguera | F. Samaniego | L. Nastoupil | N. Fowler | R. Steiner | C. Ok | Dayoung Jung | M. Badillo | Shuangtao Zhao | Guofan Xu | O. Oriabure | D. Santos | Omar Moghrabi | L. Navsaria | Saira S. Ahmed | L. Zhang | Wendy Y. Chen | Tayyaba Nizam | Chloe Marie McClain